Bradley C. Poff
Vice President, Preclinical and Clinical Developme
Clinical Research
EndotronixÂ
United States of America
Biography
Dr. Brad Poff is responsible for preclinical strategy, generating safety data for current clinical indications and investigating future applications of Endotronix technology. For 28 years he has led research teams in preclinical, clinical, and regulatory at both large and startup medical device companies. Dr. Poff was a co-founder and General Manager of Augmenix, Inc. where he built and led a team from company initiation to CE Mark approval of the lead product within 2 years. Prior to Augmenix, Dr. Poff was Vice President of Preclinical Sciences at Boston Scientific where his group supported all business units including cardiovascular, endosurgery, and neurosurgery. He was responsible for guiding business unit decision-making and speeding product introduction by developing sound safety data and regulatory messaging for Class 3 medical devices. Prior to Boston Scientific, Dr. Poff served in leadership roles at Genzyme, Focal, Guidant and 3M. He has authored or co-authored 52 papers and holds 8 patents. Dr. Poff holds a Doctorate in Veterinary Medicine (DVM) and BS from the University of Wisconsin.
Research Interest
Clinical Diagnosis and Research
